Significant Accounting Policies (Details Textual) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Mar. 13, 2017 |
Jul. 31, 2016 |
Mar. 31, 2017 |
Dec. 31, 2016 |
|
| Warrant [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 5,253,935 | 2,243,664 | ||
| Fortress Biotech, Inc [Member] | ||||
| Research and Development Asset Acquired Other than Through Business Combination, Fair Value Acquired | $ 4.4 | |||
| Stock Issued During Period, Shares, Issued for Services | 767,264 | 4.4 | 767,264 | |
| Series A Preferred Stock [Member] | ||||
| Stock Issued During Period, Shares, Issued for Services | 0 | |||
| Series A Preferred Stock [Member] | Preferred Shares [Member] | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 250,000 | 250,000 | ||
| Series A Preferred Stock [Member] | Fortress Biotech, Inc [Member] | ||||
| Stock Issued During Period, Shares, Issued for Services | 250,000 | |||
| Preferred Stock, Dividend Rate, Percentage | 2.50% |